Impact of polypharmacy on candidate biomarker mirnomes for the diagnosis of fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: Striking back on treatments

  1. Almenar-Pérez, E.
  2. Sánchez-Fito, T.
  3. Ovejero, T.
  4. Nathanson, L.
  5. Oltra, E.
Revista:
Pharmaceutics

ISSN: 1999-4923

Ano de publicación: 2019

Volume: 11

Número: 3

Tipo: Artigo

DOI: 10.3390/PHARMACEUTICS11030126 GOOGLE SCHOLAR lock_openAcceso aberto editor